Company intelligence / Profile preview

Rosesta Medical

Ownership: Private
Development stage: Other

Overview

Rosesta Medical has developed and commercialized the FERTI·LILY Conception Cup, a soft silicone vaginal device designed to increase the chances of natural conception. The product has received FDA 510(k) clearance in the United States and regulatory approval in other markets such as Japan. Clinical results are not detailed in public sources, but regulatory clearances indicate safety and substantial equivalence to predicate devices.[4][9]

Therapeutic areas: Women's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

fermata Inc. (Japan distribution partner)U.S. distribution partner (unnamed)

Beyond the preview

Go deeper on Rosesta Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosesta Medical.

Explore the full profile